Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
5/22/2013 7:01:59 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Syros Pharmaceuticals, a newly launched company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases, announced today that Eric R. Olson, Ph.D., has joined the company as its Chief Scientific Officer. Dr. Olson has over 25 years experience in the life sciences industry, most recently as Research Vice President for respiratory diseases at Vertex Pharmaceuticals. During his 12 years at Vertex he led research, development and commercial teams in bringing to patients the first cystic fibrosis (CF) treatment resulting from discovery of the CF gene.
Help employers find you! Check out all the jobs and post your resume.
comments powered by